Matches in Wikidata for { <http://www.wikidata.org/entity/Q92525267> ?p ?o ?g. }
Showing items 1 to 64 of
64
with 100 items per page.
- Q92525267 description "article scientifique publié en 2019" @default.
- Q92525267 description "artículu científicu espublizáu n'abril de 2019" @default.
- Q92525267 description "scientific article published on 09 April 2019" @default.
- Q92525267 description "wetenschappelijk artikel" @default.
- Q92525267 description "наукова стаття, опублікована 9 квітня 2019" @default.
- Q92525267 name "Single agents vs combination chemotherapy in relapsed and refractory peripheral T-cell lymphoma: Results from the comprehensive oncology measures for peripheral T-cell lymphoma treatment (COMPLETE) registry" @default.
- Q92525267 name "Single agents vs combination chemotherapy in relapsed and refractory peripheral T-cell lymphoma: Results from the comprehensive oncology measures for peripheral T-cell lymphoma treatment (COMPLETE) registry" @default.
- Q92525267 type Item @default.
- Q92525267 label "Single agents vs combination chemotherapy in relapsed and refractory peripheral T-cell lymphoma: Results from the comprehensive oncology measures for peripheral T-cell lymphoma treatment (COMPLETE) registry" @default.
- Q92525267 label "Single agents vs combination chemotherapy in relapsed and refractory peripheral T-cell lymphoma: Results from the comprehensive oncology measures for peripheral T-cell lymphoma treatment (COMPLETE) registry" @default.
- Q92525267 prefLabel "Single agents vs combination chemotherapy in relapsed and refractory peripheral T-cell lymphoma: Results from the comprehensive oncology measures for peripheral T-cell lymphoma treatment (COMPLETE) registry" @default.
- Q92525267 prefLabel "Single agents vs combination chemotherapy in relapsed and refractory peripheral T-cell lymphoma: Results from the comprehensive oncology measures for peripheral T-cell lymphoma treatment (COMPLETE) registry" @default.
- Q92525267 P1433 Q92525267-D2E07C2A-D70B-4E5E-A914-61392FA2F1E6 @default.
- Q92525267 P1476 Q92525267-365BE482-9DEB-4134-A724-DF7F50FECFE0 @default.
- Q92525267 P2093 Q92525267-0845F473-4E4D-4DC6-A618-72F25EB71AA1 @default.
- Q92525267 P2093 Q92525267-2869F9DD-190F-4E75-9AD4-DD772A622E82 @default.
- Q92525267 P2093 Q92525267-62FA42FB-A6B7-4D9D-B4C6-8769798796AD @default.
- Q92525267 P2093 Q92525267-74ED7C79-A91D-430C-95BC-7B770CA45D94 @default.
- Q92525267 P2093 Q92525267-7CED4FDB-2F36-4B8D-9332-B854FA539C53 @default.
- Q92525267 P2093 Q92525267-7DDF37ED-1E3A-4BF5-8295-1087E9E4E4F2 @default.
- Q92525267 P2093 Q92525267-B08DC5A4-A526-47F6-8462-543F517467C0 @default.
- Q92525267 P2093 Q92525267-B4B3795F-5D9A-4385-A390-412C2C2D5E11 @default.
- Q92525267 P2093 Q92525267-C8B0EDF8-0308-4B30-A0FF-25208606B9B7 @default.
- Q92525267 P2093 Q92525267-D8A4D5CF-A630-4847-815B-0B598B81E528 @default.
- Q92525267 P2093 Q92525267-DE5B8250-652D-4DCD-B0CF-D9A15DD7A3C6 @default.
- Q92525267 P304 Q92525267-A8FFCE81-38A0-409F-ACFA-D853106EF1A3 @default.
- Q92525267 P31 Q92525267-1E273DF3-0F0C-4A0A-A166-589FE3E6FCF0 @default.
- Q92525267 P356 Q92525267-AC3ABEEA-5F19-46FB-84CF-62E09532AFD3 @default.
- Q92525267 P407 Q92525267-86380EE6-1428-4188-BF36-9FDE2DA64C58 @default.
- Q92525267 P433 Q92525267-1A1C3FE8-7015-47B2-9C73-D6016B53013B @default.
- Q92525267 P478 Q92525267-5CAB8FEB-4614-40C2-9EF4-08C8B3BDD56D @default.
- Q92525267 P50 Q92525267-43849B9B-2A45-4169-BC1E-FEB76D30B402 @default.
- Q92525267 P50 Q92525267-E5003436-74C9-4D7D-99E1-BBE63215CF06 @default.
- Q92525267 P577 Q92525267-93CE6323-2505-47CD-8D3F-8C6BAD44BCF5 @default.
- Q92525267 P698 Q92525267-434EE3BE-F065-45EB-A9E8-95A5FB2ADBCF @default.
- Q92525267 P921 Q92525267-72185C01-48F0-433D-98E8-B4D7D840ADC4 @default.
- Q92525267 P932 Q92525267-7623F322-CD61-4122-966E-9605D4EF6C8A @default.
- Q92525267 P356 AJH.25463 @default.
- Q92525267 P698 30896890 @default.
- Q92525267 P1433 Q4744246 @default.
- Q92525267 P1476 "Single agents vs combination chemotherapy in relapsed and refractory peripheral T-cell lymphoma: Results from the comprehensive oncology measures for peripheral T-cell lymphoma treatment (COMPLETE) registry" @default.
- Q92525267 P2093 "Andrei R Shustov" @default.
- Q92525267 P2093 "Barbara Pro" @default.
- Q92525267 P2093 "Christian Gisselbrecht" @default.
- Q92525267 P2093 "Francine M Foss" @default.
- Q92525267 P2093 "Frederik Lansigan" @default.
- Q92525267 P2093 "Lauren C Pinter-Brown" @default.
- Q92525267 P2093 "Marc Schwartz" @default.
- Q92525267 P2093 "Mark Acosta" @default.
- Q92525267 P2093 "Massimo Federico" @default.
- Q92525267 P2093 "Niloufer Khan" @default.
- Q92525267 P2093 "Steven M Horwitz" @default.
- Q92525267 P304 "641-649" @default.
- Q92525267 P31 Q13442814 @default.
- Q92525267 P356 "10.1002/AJH.25463" @default.
- Q92525267 P407 Q1860 @default.
- Q92525267 P433 "6" @default.
- Q92525267 P478 "94" @default.
- Q92525267 P50 Q92429875 @default.
- Q92525267 P50 Q92455608 @default.
- Q92525267 P577 "2019-04-09T00:00:00Z" @default.
- Q92525267 P698 "30896890" @default.
- Q92525267 P921 Q7168693 @default.
- Q92525267 P932 "7928240" @default.